Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Diagnostic Nuclear Medicines Revenue

1.5 Market Analysis by Type

1.5.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Tc-99m

1.5.3 F-18

1.5.4 Other

1.6 Market by Application

1.6.1 Global Diagnostic Nuclear Medicines Market Share by Application: 2022-2027

1.6.2 Oncology

1.6.3 Cardiology

1.6.4 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Diagnostic Nuclear Medicines Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Diagnostic Nuclear Medicines Market Players Profiles

3.1 Bracco Imaging

3.1.1 Bracco Imaging Company Profile

3.1.2 Bracco Imaging Diagnostic Nuclear Medicines Product Specification

3.1.3 Bracco Imaging Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Bayer

3.2.1 Bayer Company Profile

3.2.2 Bayer Diagnostic Nuclear Medicines Product Specification

3.2.3 Bayer Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Curium Pharmaceuticals

3.3.1 Curium Pharmaceuticals Company Profile

3.3.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Specification

3.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Nordion

3.4.1 Nordion Company Profile

3.4.2 Nordion Diagnostic Nuclear Medicines Product Specification

3.4.3 Nordion Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Triad Isotopes

3.5.1 Triad Isotopes Company Profile

3.5.2 Triad Isotopes Diagnostic Nuclear Medicines Product Specification

3.5.3 Triad Isotopes Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Lantheus

3.6.1 Lantheus Company Profile

3.6.2 Lantheus Diagnostic Nuclear Medicines Product Specification

3.6.3 Lantheus Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 GE Healthcare

3.7.1 GE Healthcare Company Profile

3.7.2 GE Healthcare Diagnostic Nuclear Medicines Product Specification

3.7.3 GE Healthcare Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 China Isotope & Radiation

3.8.1 China Isotope & Radiation Company Profile

3.8.2 China Isotope & Radiation Diagnostic Nuclear Medicines Product Specification

3.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Jubilant Pharma

3.9.1 Jubilant Pharma Company Profile

3.9.2 Jubilant Pharma Diagnostic Nuclear Medicines Product Specification

3.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Eli Lilly

3.10.1 Eli Lilly Company Profile

3.10.2 Eli Lilly Diagnostic Nuclear Medicines Product Specification

3.10.3 Eli Lilly Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Novartis

3.11.1 Novartis Company Profile

3.11.2 Novartis Diagnostic Nuclear Medicines Product Specification

3.11.3 Novartis Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 SIEMENS

3.12.1 SIEMENS Company Profile

3.12.2 SIEMENS Diagnostic Nuclear Medicines Product Specification

3.12.3 SIEMENS Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Dongcheng

3.13.1 Dongcheng Company Profile

3.13.2 Dongcheng Diagnostic Nuclear Medicines Product Specification

3.13.3 Dongcheng Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Navidea

3.14.1 Navidea Company Profile

3.14.2 Navidea Diagnostic Nuclear Medicines Product Specification

3.14.3 Navidea Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Diagnostic Nuclear Medicines Market Competition by Market Players

4.1 Global Diagnostic Nuclear Medicines Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Market Players (2016-2021)

4.3 Global Diagnostic Nuclear Medicines Average Price by Market Players (2016-2021)

5 Global Diagnostic Nuclear Medicines Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Diagnostic Nuclear Medicines Market Size (2016-2021)

5.1.2 Diagnostic Nuclear Medicines Key Players in North America (2016-2021)

5.1.3 North America Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.1.4 North America Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Diagnostic Nuclear Medicines Market Size (2016-2021)

5.2.2 Diagnostic Nuclear Medicines Key Players in East Asia (2016-2021)

5.2.3 East Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.2.4 East Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Diagnostic Nuclear Medicines Market Size (2016-2021)

5.3.2 Diagnostic Nuclear Medicines Key Players in Europe (2016-2021)

5.3.3 Europe Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.3.4 Europe Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Diagnostic Nuclear Medicines Market Size (2016-2021)

5.4.2 Diagnostic Nuclear Medicines Key Players in South Asia (2016-2021)

5.4.3 South Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.4.4 South Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Diagnostic Nuclear Medicines Market Size (2016-2021)

5.5.2 Diagnostic Nuclear Medicines Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.5.4 Southeast Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Diagnostic Nuclear Medicines Market Size (2016-2021)

5.6.2 Diagnostic Nuclear Medicines Key Players in Middle East (2016-2021)

5.6.3 Middle East Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.6.4 Middle East Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Diagnostic Nuclear Medicines Market Size (2016-2021)

5.7.2 Diagnostic Nuclear Medicines Key Players in Africa (2016-2021)

5.7.3 Africa Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.7.4 Africa Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Diagnostic Nuclear Medicines Market Size (2016-2021)

5.8.2 Diagnostic Nuclear Medicines Key Players in Oceania (2016-2021)

5.8.3 Oceania Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.8.4 Oceania Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Diagnostic Nuclear Medicines Market Size (2016-2021)

5.9.2 Diagnostic Nuclear Medicines Key Players in South America (2016-2021)

5.9.3 South America Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.9.4 South America Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Diagnostic Nuclear Medicines Market Size (2016-2021)

5.10.2 Diagnostic Nuclear Medicines Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Diagnostic Nuclear Medicines Market Size by Type (2016-2021)

5.10.4 Rest of the World Diagnostic Nuclear Medicines Market Size by Application (2016-2021)

6 Global Diagnostic Nuclear Medicines Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Diagnostic Nuclear Medicines Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Diagnostic Nuclear Medicines Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Diagnostic Nuclear Medicines Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Diagnostic Nuclear Medicines Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Diagnostic Nuclear Medicines Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Diagnostic Nuclear Medicines Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Diagnostic Nuclear Medicines Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Diagnostic Nuclear Medicines Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Diagnostic Nuclear Medicines Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Diagnostic Nuclear Medicines Consumption by Countries

7 Global Diagnostic Nuclear Medicines Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Diagnostic Nuclear Medicines (2022-2027)

7.2 Global Forecasted Revenue of Diagnostic Nuclear Medicines (2022-2027)

7.3 Global Forecasted Price of Diagnostic Nuclear Medicines (2022-2027)

7.4 Global Forecasted Production of Diagnostic Nuclear Medicines by Region (2022-2027)

7.4.1 North America Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.3 Europe Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.7 Africa Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.9 South America Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Diagnostic Nuclear Medicines Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Diagnostic Nuclear Medicines by Application (2022-2027)

8 Global Diagnostic Nuclear Medicines Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.2 East Asia Market Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.3 Europe Market Forecasted Consumption of Diagnostic Nuclear Medicines by Countriy

8.4 South Asia Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.5 Southeast Asia Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.6 Middle East Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.7 Africa Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.8 Oceania Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.9 South America Forecasted Consumption of Diagnostic Nuclear Medicines by Country

8.10 Rest of the world Forecasted Consumption of Diagnostic Nuclear Medicines by Country

9 Global Diagnostic Nuclear Medicines Sales by Type (2016-2027)

9.1 Global Diagnostic Nuclear Medicines Historic Market Size by Type (2016-2021)

9.2 Global Diagnostic Nuclear Medicines Forecasted Market Size by Type (2022-2027)

10 Global Diagnostic Nuclear Medicines Consumption by Application (2016-2027)

10.1 Global Diagnostic Nuclear Medicines Historic Market Size by Application (2016-2021)

10.2 Global Diagnostic Nuclear Medicines Forecasted Market Size by Application (2022-2027)

11 Global Diagnostic Nuclear Medicines Manufacturing Cost Analysis

11.1 Diagnostic Nuclear Medicines Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Diagnostic Nuclear Medicines

12 Global Diagnostic Nuclear Medicines Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Diagnostic Nuclear Medicines Distributors List

12.3 Diagnostic Nuclear Medicines Customers

12.4 Diagnostic Nuclear Medicines Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Diagnostic Nuclear Medicines Revenue (US$ Million) 2016-2021

Table 6. Global Diagnostic Nuclear Medicines Market Size by Type (US$ Million): 2022-2027

Table 7. Tc-99m Features

Table 8. F-18 Features

Table 9. Other Features

Table 16. Global Diagnostic Nuclear Medicines Market Size by Application (US$ Million): 2022-2027

Table 17. Oncology Case Studies

Table 18. Cardiology Case Studies

Table 19. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Diagnostic Nuclear Medicines Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Diagnostic Nuclear Medicines Market Growth Strategy

Table 46. Diagnostic Nuclear Medicines SWOT Analysis

Table 47. Bracco Imaging Diagnostic Nuclear Medicines Product Specification

Table 48. Bracco Imaging Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Bayer Diagnostic Nuclear Medicines Product Specification

Table 50. Bayer Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Specification

Table 52. Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Nordion Diagnostic Nuclear Medicines Product Specification

Table 54. Table Nordion Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Triad Isotopes Diagnostic Nuclear Medicines Product Specification

Table 56. Triad Isotopes Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Lantheus Diagnostic Nuclear Medicines Product Specification

Table 58. Lantheus Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. GE Healthcare Diagnostic Nuclear Medicines Product Specification

Table 60. GE Healthcare Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. China Isotope & Radiation Diagnostic Nuclear Medicines Product Specification

Table 62. China Isotope & Radiation Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Jubilant Pharma Diagnostic Nuclear Medicines Product Specification

Table 64. Jubilant Pharma Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Eli Lilly Diagnostic Nuclear Medicines Product Specification

Table 66. Eli Lilly Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Novartis Diagnostic Nuclear Medicines Product Specification

Table 68. Novartis Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. SIEMENS Diagnostic Nuclear Medicines Product Specification

Table 70. SIEMENS Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Dongcheng Diagnostic Nuclear Medicines Product Specification

Table 72. Dongcheng Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Navidea Diagnostic Nuclear Medicines Product Specification

Table 74. Navidea Diagnostic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Diagnostic Nuclear Medicines Production Capacity by Market Players

Table 148. Global Diagnostic Nuclear Medicines Production by Market Players (2016-2021)

Table 149. Global Diagnostic Nuclear Medicines Production Market Share by Market Players (2016-2021)

Table 150. Global Diagnostic Nuclear Medicines Revenue by Market Players (2016-2021)

Table 151. Global Diagnostic Nuclear Medicines Revenue Share by Market Players (2016-2021)

Table 152. Global Market Diagnostic Nuclear Medicines Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 155. North America Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 157. North America Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 159. East Asia Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 162. East Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 164. East Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 166. Europe Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 169. Europe Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 171. Europe Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 173. South Asia Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 176. South Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 178. South Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 180. Southeast Asia Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 183. Southeast Asia Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 185. Southeast Asia Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 187. Middle East Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 190. Middle East Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 192. Middle East Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 194. Africa Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 197. Africa Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 199. Africa Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 201. Oceania Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 204. Oceania Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 206. Oceania Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 208. South America Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 211. South America Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 213. South America Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 215. Rest of the World Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Diagnostic Nuclear Medicines Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Diagnostic Nuclear Medicines Market Share (2016-2021)

Table 218. Rest of the World Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Diagnostic Nuclear Medicines Market Share by Type (2016-2021)

Table 220. Rest of the World Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Diagnostic Nuclear Medicines Market Share by Application (2016-2021)

Table 222. North America Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 223. East Asia Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 224. Europe Diagnostic Nuclear Medicines Consumption by Region (2016-2021)

Table 225. South Asia Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 226. Southeast Asia Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 227. Middle East Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 228. Africa Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 229. Oceania Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 230. South America Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 231. Rest of the World Diagnostic Nuclear Medicines Consumption by Countries (2016-2021)

Table 232. Global Diagnostic Nuclear Medicines Production Forecast by Region (2022-2027)

Table 233. Global Diagnostic Nuclear Medicines Sales Volume Forecast by Type (2022-2027)

Table 234. Global Diagnostic Nuclear Medicines Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Diagnostic Nuclear Medicines Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Diagnostic Nuclear Medicines Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Diagnostic Nuclear Medicines Sales Price Forecast by Type (2022-2027)

Table 238. Global Diagnostic Nuclear Medicines Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Diagnostic Nuclear Medicines Consumption Value Forecast by Application (2022-2027)

Table 240. North America Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 241. East Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 242. Europe Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 243. South Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 245. Middle East Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 246. Africa Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 247. Oceania Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 248. South America Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Diagnostic Nuclear Medicines Consumption Forecast 2022-2027 by Country

Table 250. Global Diagnostic Nuclear Medicines Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2016-2021)

Table 252. Global Diagnostic Nuclear Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2022-2027)

Table 254. Global Diagnostic Nuclear Medicines Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2016-2021)

Table 256. Global Diagnostic Nuclear Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2022-2027)

Table 258. Diagnostic Nuclear Medicines Distributors List

Table 259. Diagnostic Nuclear Medicines Customers List





Figure 1. Product Figure

Figure 2. Global Diagnostic Nuclear Medicines Market Share by Type: 2021 VS 2027

Figure 3. Global Diagnostic Nuclear Medicines Market Share by Application: 2021 VS 2027

Figure 4. North America Diagnostic Nuclear Medicines Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 6. North America Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 7. United States Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 8. Canada Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 12. China Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 13. Japan Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 15. Europe Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 16. Europe Diagnostic Nuclear Medicines Consumption Market Share by Region in 2021

Figure 17. Germany Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 19. France Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 20. Italy Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 21. Russia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 22. Spain Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 25. Poland Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 27. South Asia Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 28. India Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 30. Southeast Asia Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 31. Indonesia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 37. Middle East Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 38. Turkey Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 40. Iran Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 42. Africa Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 43. Africa Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 44. Nigeria Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 47. Oceania Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 48. Australia Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 49. South America Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 50. South America Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 51. Brazil Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Diagnostic Nuclear Medicines Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Diagnostic Nuclear Medicines Consumption and Growth Rate

Figure 54. Rest of the World Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2021

Figure 55. Global Diagnostic Nuclear Medicines Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Diagnostic Nuclear Medicines Price and Trend Forecast (2022-2027)

Figure 58. North America Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 59. North America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 75. South America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Diagnostic Nuclear Medicines Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 79. East Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 80. Europe Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 81. South Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 82. Southeast Asia Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 83. Middle East Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 84. Africa Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 85. Oceania Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 86. South America Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 87. Rest of the world Diagnostic Nuclear Medicines Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Diagnostic Nuclear Medicines

Figure 89. Manufacturing Process Analysis of Diagnostic Nuclear Medicines

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Diagnostic Nuclear Medicines Supply Chain Analysis